Literature DB >> 21213114

Efficacy of calcium supplementation for human bone health by mass spectrometry profiling and cathepsin K measurement in plasma samples.

Yingchun Zhao1, Rui Cao, Danjun Ma, Hengwei Zhang, Joan Lappe, Robert R Recker, Gary Guishan Xiao.   

Abstract

Osteoporosis is a common disease among older people, especially postmenopausal women. Calcium supplementation is effective in decreasing the occurrence of osteoporosis. We tested the effect of different calcium sources (i.e., calcium carbonate chew, milk mineral chew, milk drink and placebo chew) by direct mass spectrometry (dMS) profiling and cathepsin K measurement in the serum of subjects. The dMS method is promising for plasma biomarker discovery, and cathepsin K level in the plasma is an indicator for osteoporosis. Our result shows that dMS detected characteristic ion peaks after different calcium supplement interventions; ion peak 4281.0 m/z was commonly inhibited by all three treatments. This ion peak was identified to be a fragment of follistatin-related protein 3 precursor by means of the "Lift" mode of MS/MS. The other differential ion peaks were also successfully identified: 1786.5 m/z (upregulated after calcium carbonate chew) was shown to be one fragment of transcription factor jun-B; the parent protein of 3504.7 m/z (upregulated after milk drink) was a collagen alpha-2 (type I) chain precursor; the ion peak of 3359.6 m/z (downregulated after milk mineral chew) was one fragment of family 31 glucosidase. Cathepsin K is significantly inhibited only by calcium carbonate chew treatment, indicating this form of calcium supplement has some advantage over other sources of supplementation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213114     DOI: 10.1007/s00774-010-0251-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  35 in total

1.  Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption.

Authors:  R A Dodds; I E James; D Rieman; R Ahern; S M Hwang; J R Connor; S D Thompson; D F Veber; F H Drake; S Holmes; M W Lark; M Gowen
Journal:  J Bone Miner Res       Date:  2001-03       Impact factor: 6.741

2.  Microfibrillar structure of type I collagen in situ.

Authors:  Joseph P R O Orgel; Thomas C Irving; Andrew Miller; Tim J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

3.  Detection of serum proteomic changes and discovery of serum biomarkers for Kashin-Beck disease using surface-enhanced laser desorption ionization mass spectrometry (SELDI-TOF MS).

Authors:  Shuang Wang; Xiong Guo; Wu-Hong Tan; Dong Geng; Bi-Ping Deng; Chun-e Wang; Xun Qu
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

4.  Human follistatin-related protein: a structural homologue of follistatin with nuclear localization.

Authors:  D V Tortoriello; Y Sidis; D A Holtzman; W E Holmes; A L Schneyer
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

5.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

Review 6.  The bioavailability of dietary calcium.

Authors:  L Guéguen; A Pointillart
Journal:  J Am Coll Nutr       Date:  2000-04       Impact factor: 3.169

Review 7.  NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake.

Authors: 
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

Review 8.  Differential actions of follistatin and follistatin-like 3.

Authors:  Alan Schneyer; Yisrael Sidis; Yin Xia; Seiichiro Saito; Elisabetta del Re; Herbert Y Lin; Henry Keutmann
Journal:  Mol Cell Endocrinol       Date:  2004-10-15       Impact factor: 4.102

9.  Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin.

Authors:  C Tepel; D Brömme; V Herzog; K Brix
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

10.  Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects.

Authors:  Lukas Kenner; Astrid Hoebertz; F Timo Beil; Timo Beil; Niamh Keon; Florian Karreth; Robert Eferl; Harald Scheuch; Agnieszka Szremska; Michael Amling; Marina Schorpp-Kistner; Peter Angel; Erwin F Wagner
Journal:  J Cell Biol       Date:  2004-02-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.